Submitted by Anonymous (not verified) on 19 February 2026 - 12:40
Human medicines European public assessment report (EPAR): Enrylaze, crisantaspase, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enrylaze, crisantaspase, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised